Clark Estates Inc’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Clark Estates Inc’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-272,500	Closed	-$4.89M	–	104
2017 Q4	$4.89M	Hold	272,500	–	–	0.81%	24
2017 Q3	$3.22M	Buy	272,500 +22,500	+9%	+$252K	0.53%	61
2017 Q2	$2.63M	Hold	250,000	–	–	0.45%	72
2017 Q1	$2.75M	Hold	250,000	–	–	0.42%	61
2016 Q4	$3.39M	Buy	250,000 +25,000	+11%	+$349K	0.57%	44
2016 Q3	$2.77M	Hold	225,000	–	–	0.54%	50
2016 Q2	$2.47M	Buy	+225,000	New	+$2.52M	0.49%	60

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Clark Estates Inc's SCMP Position: Q1 2018 in Review

Clark Estates Inc sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 272,500 shares — an estimated $4.89M sold.

Clark Estates Inc first reported a position in SCMP in Q2 2016 and held it in 7 quarters. The position peaked at $4.89M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Clark Estates Inc reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Clark Estates Inc sold 272,500 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $4.89M.
Clark Estates Inc first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2016 and held it in 7 quarters.
Clark Estates Inc's Sucampo Pharmaceuticals, Inc. position peaked at $4.89M in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Clark Estates Inc's 13F filing for Q1 2018, filed 18 Apr 2018.